Claims for Patent: 10,105,444

Summary for Patent: 10,105,444

Title:	Compositions and methods for treating diseases of the nail
Abstract:	Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, which composition has a surface tension of 40 dynes/cm or less and has continuing spreadability, and which composition is effective in treating a disorder of the nail or nail bed.
Inventor(s):	Winckle; Gareth (Petaluma, CA), Fieldson; Gregory T. (Morgantown, WV)
Assignee:	Dow Pharmaceutical Sciences, Inc. (Petaluma, CA)
Application Number:	15/826,109
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,105,444
Patent Claims:	1. A pharmaceutical formulation comprising a. ethanol, 50% to 70% (w/w), b. cyclomethicone, 10% to 15% (w/w), c. diisopropyl adipate, 8% to 15% (w/w), d. C12-15 alkyl lactate, 8% to 15% (w/w), and e. antioxidant, 0.001% to 0.50% (w/w), wherein the surface tension of the composition is 40 dynes/cm or less; and wherein the formulation is free of polymeric film forming compounds. 2. The pharmaceutical formulation of claim 1, wherein the formulation is for delivery of an active pharmaceutical ingredient to the nail or nail bed. 3. The pharmaceutical formulation of claim 1, wherein the surface tension is 35 dynes/cm or less. 4. The pharmaceutical formulation of claim 3, wherein the surface tension is 30 dynes/cm or less. 5. The pharmaceutical formulation of claim 4, wherein the surface tension is 25 dynes/cm or less. 6. The pharmaceutical formulation of claim 1, further comprising an antifungal active pharmaceutical ingredient. 7. The pharmaceutical formulation of claim 6, wherein the antifungal active pharmaceutical ingredient comprises an imidazole or a triazole compound. 8. The pharmaceutical formulation of claim 6, wherein the antifungal active pharmaceutical ingredient is selected from the group consisting of miconazole, ketoconazole, clotrimazole, econazole, bifonazole, butoconazole, fenticonazole, isoconazole, oxiconazole, sertaconazole, suconazole, tioconazole, fluconazole, itraconazole, ravuconazole, posaconazole, voriconazole, terconazole, and (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4- -triazole-1-yl)butane-2-ol. 9. A method for the treatment of a disorder of the nail or nail bed comprising topically applying to the surface of the nail of an individual suffering from said disorder a pharmaceutical composition comprising an active pharmaceutical ingredient and (a) ethanol, in an amount of 50% to 70% (w/w); (b) cyclomethicone, in an amount of 10% to 15% (w/w); (c) diisopropyl adipate, in an amount of 8% to 15% (w/w); (d) C12-15 alkyl lactate, in an amount of 8% to 15% (w/w); and (e) antioxidant, in an amount of 0.001% to 0.50% (w/w); wherein the application of the composition is in an amount and for a time sufficient to ameliorate the signs and symptoms of the disorder, wherein the surface tension of the composition is 40 dynes/cm or less, and wherein the composition, when applied to the surface of a nail, does not form a solid film.